NxStage Medical, Inc. (NXTM) has 139 open-market insider trades by 28 insiders since 2006. The most active filer is Winifred L. Swan, CLO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | Dir | — | 7 | $58.3M | 2010-10-13 |
| Philippe Chambon | Dir | — | 10 | $33.3M | 2011-01-26 |
| Suisse Ag/ Credit | 10% | — | 10 | $29.4M | 2010-11-08 |
| David S. Utterberg | Dir | — | 2 | $11.9M | 2013-01-03 |
| Suisse/ Credit | 10% | — | 3 | $8.3M | 2008-08-01 |
| Robert S. Brown | Pres | — | 12 | $5.0M | 2017-04-03 |
| Philippe O. Chambon | Dir | — | 5 | $4.9M | 2013-03-29 |
| Joseph E. Turk Jr. | Pres | — | 11 | $2.9M | 2018-05-21 |
| Jeffrey H. Burbank | CEO | — | 14 | $2.5M | 2019-02-21 |
| Winifred L. Swan | CLOVP | — | 17 | $2.4M | 2019-02-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Winifred L. Swan | CLO & VP | Sell | $86K | 2018-02-20 |
| Winifred L. Swan | CLO & VP | Sell | $87K | 2018-01-16 |
| Winifred L. Swan | CLO & VP | Sell | $89K | 2017-12-20 |
| Winifred L. Swan | CLO & VP | Sell | $90K | 2017-11-15 |
| Matthew W. Towse | VP | Sell | $111K | 2017-10-20 |
| Winifred L. Swan | CLO & VP | Sell | $96K | 2017-10-20 |
Companies that share insiders with NXTM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Joseph E. Turk Jr. | President | Sell | $28K | 2017-10-04 |
| Matthew W. Towse | VP | Sell | $117K | 2017-09-20 |
| Winifred L. Swan | CLO & VP | Sell | $95K | 2017-09-20 |
| Joseph E. Turk Jr. | President | Sell | $28K | 2017-09-05 |
| Matthew W. Towse | VP | Sell | $126K | 2017-08-21 |
| Winifred L. Swan | CLO & VP | Sell | $102K | 2017-08-15 |
| Joseph E. Turk Jr. | President | Sell | $29K | 2017-08-10 |
| Joseph E. Turk Jr. | President | Sell | $711K | 2017-08-07 |
| Joseph E. Turk Jr. | President | Sell | $161K | 2017-08-03 |